Kaiser Permanente Ventures
Kaiser Permanente Ventures is a corporate venture capital firm investing in healthcare companies.
Business Model:
Revenue: $15M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Kaiser Permanente Ventures Information
Geographic Data
Address: 1 Kaiser Plaza
City: Oakland
State: CA
Zip: 94612
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$141M
Social
Facebook
Twitter
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Kaiser Permanente Ventures, the corporate venture capital arm of Kaiser Permanente, is dedicated to forming effective partnerships with innovative companies. Kaiser Permanente Ventures invests predominantly in HCIT and services, as well as diagnostics, drug delivery and therapeutic medical devices.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 4/2013 | iRhythm Technologies | Series D | 16M |
| 1/2012 | iRhythm Technologies | Private Equity Round | 12.2M |
| 4/2014 | Vapotherm | Series B | 0 |
| 6/2004 | Proteus Digital Health | Series B | 6.3M |
| 1/2020 | Vesta Healthcare | Series A | 30M |
| 8/2005 | Adiana | Series D | 23M |
| 1/2012 | Transcend Medical | Series B | 16M |
| 6/2013 | Movable | Seed | 1.9M |
| 10/2009 | Accumetrics | Series E | 0 |
| 9/2010 | Accumetrics | Venture Round | 0 |
| 12/2014 | Ginger | Series B | 20M |
| 7/2016 | Big Health | Series B | 0 |
| 4/2013 | Nordic | Venture Round | 5M |
| 6/2012 | Oxford Immunotec | Equity | 28M |
| 4/2013 | AtheroMed | Private Equity Round | 6M |
| 12/2004 | Radianse | Venture Round | 2M |
| 1/2015 | Ingenious Med | Venture Round | - |
| 2/2016 | CareGuardian | Series B | 5M |
| 11/2022 | Validic | Venture Round | 12M |
| 1/2018 | Genome Medical | Series A | 11M |
| 11/2011 | Xanitos | Venture Round | 0 |
| 11/2020 | Kate Farms | Series B | 51M |
| 6/2011 | Transcend Medical | Series B | 51M |
| 7/2016 | Torax Medical | Series E | 0 |
| 11/2003 | NeoGuide Systems | Series B | 0 |
| 2/2019 | Health Catalyst | Series F | 0 |
| 9/2009 | ValenTx | Series B | 0 |
| 11/2001 | NextWeb | Series C | - |
| 4/2014 | Omada Health | Series B | 23M |
| 3/2012 | AtheroMed | Series D | 4.5M |
| 1/2008 | Arbor Surgical Technologies | Series C | 0 |
| 4/2007 | Bacchus Vascular | Venture Round | 6.5M |
| 8/2020 | Freenome | Series C | 270M |
| 10/2008 | Predictive Biosciences | Series B | 21.8M |
| 9/2011 | Valeritas | Series C | 150M |
| 7/2021 | Osso VR | Series B | 0 |
| 8/2022 | Everytable | Series C | 0 |
| 4/2010 | Hemosphere | Series A | 9.3M |
| 4/2022 | IntelyCare | Series C | 0 |
| 4/2014 | Transcend Medical | Series C | 0 |
| 1/2022 | Big Health | Series C | 0 |
| 8/2009 | Silverlink Communications | Series D | 5M |
| 9/2016 | Chrono Therapeutics | Series B | 47.6M |
| 7/2019 | Nuvolo | Series B | 12M |
| 6/2010 | Agile Therapeutics | Series B | 0 |
| 1/2007 | Calypso Medical | Series D | 42.2M |
| 9/2022 | Kate Farms | Series C | 75M |
| 7/2012 | Agile Therapeutics | Series C | 0 |
| 12/2015 | Vidyo | Series E | 15M |
| 9/2013 | Xanitos | Venture Round | 0 |
| 2/2009 | Arcxis Biotechnologies | Series B | - |
| 6/2016 | Bluesight | Series C | 20.4M |
| 3/2020 | Ordr | Series B | 6M |
| 6/2010 | Baxano | Series C | 30M |
| 1/2015 | Bluesight | Series B | 12M |
| 4/2015 | Validic | Series B | 12.5M |
| 6/2020 | Big Health | Series B | 39M |
| 2/2020 | IntelyCare | Series B | 45M |
| 11/2020 | Everytable | Series B | 0 |
| 3/2021 | Evidation Health | Series E | 153M |
| 3/2022 | Osso VR | Series C | 0 |
| 6/2012 | Astute Medical | Series C | 40.4M |
| 2/2019 | Health Catalyst | Debt Financing | 0 |
| 1/2014 | Health Catalyst | Series C | 0 |
| 10/2022 | NorthOne | Series B | 0 |
| 6/2022 | Ordr | Series C | 0 |
| 2/2008 | Accumetrics | Series D | 0 |
| 11/2015 | Vapotherm | Series C | 0 |
| 4/2013 | Vapotherm | Series A | 0 |
| 1/2005 | GeneOhm Sciences | Series C | 0 |
| 6/2012 | TriVascular | Series D | 60M |
| 7/2014 | Valeritas | Series D | 45M |
| 7/2019 | Freenome | Series B | 160M |
| 9/2019 | Ginger | Series C | 0 |
| 8/2021 | Genome Medical | Series C | 0 |
| 1/2023 | NOCD | Series B | 0 |
| 3/2021 | DexCare | Series A | 0 |
| 6/2023 | DexCare | Series C | 0 |
| 2/2008 | Zonare Medical Systems | Equity | 30M |
| 3/2021 | Nuvolo | Series C | 32M |
| 3/2015 | Health Catalyst | Series D | 0 |
| 7/2017 | Protenus | Series A | 3M |
| 7/2015 | Vapotherm | Series C | 0 |
| 11/2002 | NextWeb | Series D | 1.5M |
| 11/2017 | Collective Medical Technologies | Series A | 47.5M |
| 8/2021 | Abogen Biosciences | Series C | 0 |
| 1/2005 | CHF Solutions | Venture Round | 22.9M |
| 9/2012 | Torax Medical | Series D | 0 |
| 9/2020 | Osso VR | Series A | 14M |
| 3/2013 | Health Catalyst | Series B | 0 |
| 5/2010 | Oxford Immunotec | Series D | 26M |
| 11/2013 | TriVascular | Series E | 0 |
| 11/2007 | Vapotherm | Series E | 11.3M |
| 8/2008 | Vapotherm | Series F | 20.5M |
| 9/2014 | MetricStream | Private Equity Round | 60M |
| 3/2012 | GluMetrics | Venture Round | 13.3M |
| 11/2018 | Vesta Healthcare | Series A | 10M |
| 7/2020 | Genome Medical | Series B | 0 |
| 6/2010 | Predictive Biosciences | Series C | 25M |
| 9/2021 | NOCD | Series B | 0 |
| 6/2021 | Protenus | Series D | 0 |
| 1/2018 | Protenus | Series B | 11M |
| 4/2005 | BDNA | Series C | 12.5M |
| 1/2013 | Nordic | Funding Round | 38.3M |
| 1/2012 | CytoPherx | Series C | 34M |
| 8/2020 | Ginger | Series D | 0 |
| 6/2016 | Kit Check | Series C | 0 |
| 8/2005 | NextWeb | Series E | 3.5M |
| 8/2019 | Protenus | Series C | 0 |
| 5/2021 | Groups Recover Together | Series C | 60M |
| 1/2015 | Kit Check | Series B | 12M |
| 8/2022 | Everytable | Series C | 0 |
| 6/2022 | Ordr | Series C | 0 |
| 4/2022 | IntelyCare | Series C | 0 |
| 3/2022 | Osso VR | Series C | 0 |
| 1/2022 | Big Health | Series C | 0 |
| 9/2021 | NOCD | Series B | 0 |
| 8/2021 | Genome Medical | Series C | 0 |
| 8/2021 | Abogen Biosciences | Series C | 0 |
| 7/2021 | Osso VR | Series B | 0 |
| 6/2021 | Protenus | Series D | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
